Q-linea ABOSTO:QLINEA +0.84%67 Beneish M-Score is 16.57 as of Jun. 28, 2026, which is 1478% above its 10-year median of 1.05. GuruFocus rates OSTO:QLINEA with a GF Score™ of 67/100 and a GF Value™ of kr19.86 (Fairly Valued). The stock has 3 warning signs investors should review. Among 766 Medical Devices & Instruments companies, Q-linea AB ranks worse than 98.83% on this metric.
The zones of discrimination for M-Score is as such:
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Warning Sign:
Beneish M-Score 16.57 higher than -1.78, which implies that the company might have manipulated its financial results.
The historical rank and industry rank for Q-linea AB's Beneish M-Score or its related term are showing as below:
OSTO:QLINEA'
s Beneish M-Score Range Over the Past 10 Years
Min: -7.48 Med: 1.05 Max: 374.38
Current: 16.57
During the past 11 years, the highest Beneish M-Score of Q-linea AB was 374.38. The lowest was -7.48. And the median was 1.05.
Q-linea AB Beneish M-Score Related Terms
Q-linea AB Beneish M-Score Historical Data
* Premium members only.
The historical data trend for Q-linea AB's Beneish M-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:QLINEA vs ABT, SYK, MDT: Beneish M-Score Comparison
For the Medical Devices subindustry, Q-linea AB's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Q-linea AB Beneish M-Score vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Q-linea AB's Beneish M-Score distribution charts can be found below:
* The bar in red indicates where Q-linea AB's Beneish M-Score falls into.
The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.
The M-Score Variables:
The M-score of Q-linea AB for today is based on a combination of the following eight different indices:
M
=
-4.84
+
0.92 * DSRI
+
0.528 * GMI
+
0.404 * AQI
+
0.892 * SGI
+
0.115 * DEPI
=
-4.84
+
0.92 * 1.2548
+
0.528 * 30.8418
+
0.404 * 0.3109
+
0.892 * 4.6986
+
0.115 * 0.939
-
0.172 * SGAI
+
4.679 * TATA
-
0.327 * LVGI
-
0.172 * 1
+
4.679 * -0.05509
-
0.327 * 0.0723
=
16.57
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.
DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.
DEPI
=
(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))
/
(Depreciation_t / (Depreciaton_t + PPE_t))
=
(17.763 / (17.763 + 41.98))
/
(15.163 / (15.163 + 32.722))
=
0.297324
/
0.316654
=
0.939
Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.
6. SGAI = Sales, General and Administrative expenses Index
Total accruals calculated as the change in working capital accounts other than cash less depreciation.
TATA
=
(IncomefromContinuingOperations_t
-
CashFlowsfromOperations_t)
/
TotalAssets_t
=
(NetIncome_t - NonOperatingIncome_t
-
CashFlowsfromOperations_t)
/
TotalAssets_t
=
(-182.485 - 0
-
-162.12)
/
369.668
=
-0.05509
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Q-linea AB has a M-score of 16.57 signals that the company is likely to be a manipulator.
Q-linea AB (OSTO:QLINEA) has a Beneish M-Score of 16.57 as of Jun. 28, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Q-linea AB and its competitors. This is 1478% above median its historical median of 1.05. According to the industry distribution chart, Q-linea AB ranks #757 out of 766 companies in the Medical Devices & Instruments industry, placing it in the top 98.8%.
Is Q-linea AB's Beneish M-Score too high?
Q-linea AB's current Beneish M-Score of 16.57 is 1478% above median its 10-year median of 1.05. Based on the distribution chart, Q-linea AB ranks #757 out of 766 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Q-linea AB has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Q-linea AB's Beneish M-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Q-linea AB ranks #757 out of 766 companies for Beneish M-Score. This places Q-linea AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Q-linea AB and its competitors. Q-linea AB's current Beneish M-Score is 16.57, which is 1478% above median its own 10-year median of 1.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q-linea AB stock overvalued right now?
Based on GuruFocus' analysis, Q-linea AB (OSTO:QLINEA) is currently considered Fairly Valued. The stock's GF Value™ is kr19.86, compared to a current price of kr18.10 — trading 8.9% below its estimated fair value. The current Beneish M-Score is 16.57, which is 1478% above median its 10-year median of 1.05. Q-linea AB's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Q-linea AB (OSTO:QLINEA), the current Beneish M-Score is 16.57 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Q-linea AB (OSTO:QLINEA) Overvalued in 2026?
Based on GuruFocus' analysis, Q-linea AB stock appears to be undervalued.
The current stock price of kr18.10 is trading 8.9% below its estimated GF Value™ of kr19.86.
GuruFocus considers Q-linea AB to be Fairly Valued.
Key valuation signals for OSTO:QLINEA:
Beneish M-Score: 16.57 (1478% above median its 10-year median of 1.05)
GF Value™: kr19.86 vs. price of kr18.10 (8.9% below fair value)
No single metric tells the full story. See the OSTO:QLINEA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Q-linea AB is a company that develops infection diagnostics solutions that benefit patients, healthcare providers, and society, enabling rapid diagnosis of blood infections such as sepsis within six hours of a positive blood culture. It focuses on developing instruments and consumables that benefit patients, healthcare providers, and society. It develops and delivers solutions for healthcare providers, enabling them to diagnose and treat infectious diseases in the shortest possible time. The company's product, ASTar, is a fully automated instrument (AST, antibiotic susceptibility testing), which produces a sensitivity profile from a positive blood culture.
67GF Score
Get the complete analysis for OSTO:QLINEA
Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:QLINEA has been successfully added to your 
